MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Non-motor symptoms in progressive supranuclear palsy

    R. Ou, W. Song, Q. Wei, K. Chen, B. Cao, Y. Hou, B. Zhao, H. Shang (Chengdu, People's Republic of China)

    Objective: To explore the clinical correlates of Non-motor symptoms (NMS) in progressive supranuclear palsy (PSP) and their differences from healthy aging and Parkinson's disease (PD).…
  • 2016 International Congress

    Apraxia of speech as the initial manifestation of progressive supranuclear palsy

    J.J. Bravo, M.J. Gallardo, J.P. Cabello, R.E. Ibañez, J. Vaamonde (Ciudad Real, Spain)

    Objective: We report a patient with apraxia of speech as the initial symptom who finally developed a progressive supranuclear palsy. Background: Progressive supranuclear palsy (PSP)…
  • 2016 International Congress

    A case series of sigmoid volvulus in Parkinson’s disease

    K. Khalid, A. McColl, M. Gosney, A.K. Chatterjee (Reading, United Kingdom)

    Objective: To study the outcomes of patients with Parkinson's disease (PD) who were admitted with a diagnosis of sigmoid volvulus. Background: Constipation is a common…
  • 2016 International Congress

    Carrier mediated delivery system bearing dopamine for effective management of parkinsonism

    V. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposome bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • 2016 International Congress

    Progressive ataxia and palatal tremor: A case report

    G. Fabiani, J. Yared, H.A.G. Teive (Campina Grande do Sul, Brazil)

    Objective: To report a case of sporadic progressive ataxia and palatal tremor (PAPT). Background: PAPT is a rare disease with few case reports. It is…
  • 2016 International Congress

    Incidence of dystonia in patients with progressive supranuclear palsy

    E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva (Taskent, Uzbekistan)

    Objective: To study the frequency of dystonic symptoms in progressive supranuclear palsy (PSP). Background: Progressive supranuclear palsy (PSP) is an uncommon brain disorder that affects…
  • 2016 International Congress

    Clinical predictors of progressive supranuclear palsy (PSP) pathology in PSP syndrome

    I. Aiba, Y. Saito, Y. Yokokawa, M. Kenjo, T. Katayama, R. Hashimoto, S. Sakakibara, A. Inukai, M. Mimuro, Y. Iwasaki, M. Yoshida (Nagoya, Japan)

    Objective: To elucidate specific clinical features of progressive supranuclear palsy (PSP) pathology in PSP syndrome. Background: PSP syndrome (PSPS) is the clinical hallmark of PSP;…
  • 2016 International Congress

    Modeling trajectories of brain damage in progressive supranuclear palsy: A longitudinal multimodal MRI study

    F. Caso, F. Agosta, M. Lukic-Jecmenica, I. Petrovic, P. Valsasina, P.M. Ferraro, A. Meani, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

    Objective: To explore longitudinally clinical, cognitive, and neuroimaging changes in patients with progressive supranuclear palsy syndrome (PSPs). Background: PSP is a progressive neurodegenerative disease. Longitudinal…
  • 2016 International Congress

    Innsbruck multiple system atrophy cohort study – An interim analysis

    S. Eschlböck, T. Benke, S. Bösch, A. Djamshidian-Tehrani1, A. Fanciulli, R. Granata, C. Kaindlstorfer, G. Kiss, F. Krismer, K. Mair, M. Nocker, C. Raccagni, C. Scherfler, K. Seppi, W. Poewe, G. Wenning (Innsbruck, Austria)

    Objective: To characterize the clinical presentation, to identify markers of disease progression and to assess diagnostic utility of 'red flags' in subjects with multiple system…
  • 2016 International Congress

    Theta burst repetitive transcranial magnetic stimulation in a case with cortical-basal ganglionic degeneration

    A. Demirtas-Tatlidede, Z. Matur, B. Bilgic, H. Hanagasi, M. Emre, H. Gurvit, E. Oge (Istanbul, Turkey)

    Objective: Corticobasal ganglionic degeneration (CBGD) is a progressive taupathy involving frontal and parietal cortices as well as basal ganglia. The disease is clinically characterized by…
  • « Previous Page
  • 1
  • …
  • 181
  • 182
  • 183
  • 184
  • 185
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley